|
1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine |
|
CHEBI:74348 |
|
1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine |
|
A lysophosphatidylcholine 22:5 in which the acyl group at position 1 is (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl and the hydroxy group at position 2 is unsubstituted. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C30H52NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-30(33)36-27-29(32)28-38-39(34,35)37-26-25-31(2,3)4/h9-10,12-13,15-16,18-19,21-22,29,32H,5-8,11,14,17,20,23-28H2,1-4H3/b10-9-,13-12-,16-15-,19-18-,22-21-/t29-/m1/s1 |
YBUXFQUGNPBZPS-YNBHEIDWSA-N |
O(C(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)C[C@H](COP(OCC[N+](C)(C)C)(=O)[O-])O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via lysophosphatidylcholine 22:5 )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via lysophosphatidylcholine )
|
|
View more via ChEBI Ontology
Outgoing
|
1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:74348)
has functional parent
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid
(CHEBI:65136)
1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:74348)
is a
1-O-acyl-sn-glycero-3-phosphocholine
(CHEBI:58168)
1-[(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl]-sn-glycero-3-phosphocholine
(CHEBI:74348)
is a
lysophosphatidylcholine (22:5/0:0)
(CHEBI:131985)
|
|
(2R)-3-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-2-hydroxypropyl 2-(trimethylammonio)ethyl phosphate
|
1-(4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl-sn-glycero-3-phosphocholine
|
UniProt
|
1-Docosapentaenoyl-glycero-3-phosphocholine
|
HMDB
|
1-docosapentaenoyl-GPC
|
ChEBI
|
1-docosapentaenoyl-GPC (22:5n6)
|
ChEBI
|
1-Osbondoyl-glycero-3-phosphocholine
|
HMDB
|
GPC(22:5n6)
|
ChEBI
|
LPC 22:5(4Z,7Z,10Z,13Z,16Z)/0:0
|
ChEBI
|
LPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
|
ChEBI
|
LysoPC 22:5(4Z,7Z,10Z,13Z,16Z)/0:0
|
ChEBI
|
LysoPC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
|
ChEBI
|
lysophosphatidylcholine(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
|
ChEBI
|
PC 22:5(4Z,7Z,10Z,13Z,16Z)/0:0
|
ChEBI
|
PC(22:5(4Z,7Z,10Z,13Z,16Z)/0:0)
|
ChEBI
|
PC(22:5n6)
|
ChEBI
|
|